INTRODUCTION: We developed models of Specialized Care for Bipolar Disorder (SCBD) and a psychosocial treatment [Enhanced Clinical Intervention (ECI)] that is delivered in combination with SCBD. We investigated whether SCBD and ECI + SCBD are able to improve outcomes and reduce health disparities for young and elderly individuals, African Americans, and rural residents with bipolar disorder. METHOD:Subjects were 463 individuals with bipolar disorder, type I, II, or not otherwise specified, or schizoaffective disorder, bipolar type, randomly assigned to SCBD or ECI + SCBD and followed longitudinally for a period of one to three years at four clinical sites. RESULTS: Both treatment groups significantly improved over time, with no significant differences based on age, race, or place of residence, except for significantly greater improvement among elderly versus adult subjects. Improvement in quality of life was greater in the ECI + SCBD group. Of the 299 participants who were symptomatic at study entry, 213 achieved recovery within 24 months, during which 86 of the 213 subjects developed a new episode. No significant difference was found for race, place of residence, or age between the participants who experienced a recurrence and those who did not. However, the adolescent patients were less likely than the adult and elderly patients to experience a recurrence. CONCLUSION: This study demonstrated the effectiveness of SCBD and the additional benefit of ECI independent of age, race, or place of residence. It also demonstrated that new mood episodes are frequent in individuals with bipolar disorder who achieve recovery and are likely to occur in spite of specialized, guideline-based treatments.
RCT Entities:
INTRODUCTION: We developed models of Specialized Care for Bipolar Disorder (SCBD) and a psychosocial treatment [Enhanced Clinical Intervention (ECI)] that is delivered in combination with SCBD. We investigated whether SCBD and ECI + SCBD are able to improve outcomes and reduce health disparities for young and elderly individuals, African Americans, and rural residents with bipolar disorder. METHOD: Subjects were 463 individuals with bipolar disorder, type I, II, or not otherwise specified, or schizoaffective disorder, bipolar type, randomly assigned to SCBD or ECI + SCBD and followed longitudinally for a period of one to three years at four clinical sites. RESULTS: Both treatment groups significantly improved over time, with no significant differences based on age, race, or place of residence, except for significantly greater improvement among elderly versus adult subjects. Improvement in quality of life was greater in the ECI + SCBD group. Of the 299 participants who were symptomatic at study entry, 213 achieved recovery within 24 months, during which 86 of the 213 subjects developed a new episode. No significant difference was found for race, place of residence, or age between the participants who experienced a recurrence and those who did not. However, the adolescent patients were less likely than the adult and elderly patients to experience a recurrence. CONCLUSION: This study demonstrated the effectiveness of SCBD and the additional benefit of ECI independent of age, race, or place of residence. It also demonstrated that new mood episodes are frequent in individuals with bipolar disorder who achieve recovery and are likely to occur in spite of specialized, guideline-based treatments.
Authors: J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan Journal: J Am Acad Child Adolesc Psychiatry Date: 1997-07 Impact factor: 8.829
Authors: Ellen Frank; David J Kupfer; Michael E Thase; Alan G Mallinger; Holly A Swartz; Andrea M Fagiolini; Victoria Grochocinski; Patricia Houck; John Scott; Wesley Thompson; Timothy Monk Journal: Arch Gen Psychiatry Date: 2005-09
Authors: Amy M Kilbourne; Mark S Bauer; Xiaoyan Han; Gretchen L Haas; Patrick Elder; Chester B Good; Mujeeb Shad; Joseph Conigliaro; Harold Pincus Journal: Psychiatr Serv Date: 2005-12 Impact factor: 3.084
Authors: Naomi M Simon; Michael W Otto; Stephen R Wisniewski; Mark Fossey; Kemal Sagduyu; Ellen Frank; Gary S Sachs; Andrew A Nierenberg; Michael E Thase; Mark H Pollack Journal: Am J Psychiatry Date: 2004-12 Impact factor: 18.112
Authors: Ivan W Miller; Lisa A Uebelacker; Gabor I Keitner; Christine E Ryan; David A Solomon Journal: Compr Psychiatry Date: 2004 Nov-Dec Impact factor: 3.735
Authors: Roy H Perlis; Michael J Ostacher; Jayendra K Patel; Lauren B Marangell; Hongwei Zhang; Stephen R Wisniewski; Terence A Ketter; David J Miklowitz; Michael W Otto; Laszlo Gyulai; Noreen A Reilly-Harrington; Andrew A Nierenberg; Gary S Sachs; Michael E Thase Journal: Am J Psychiatry Date: 2006-02 Impact factor: 18.112
Authors: Robert C Young; Laszlo Gyulai; Benoit H Mulsant; Alastair Flint; John L Beyer; Kenneth I Shulman; Charles F Reynolds Journal: Am J Geriatr Psychiatry Date: 2004 Jul-Aug Impact factor: 4.105
Authors: Ariel G Gildengers; Meryl A Butters; Denise Chisholm; Stewart J Anderson; Amy Begley; Margo Holm; Joan C Rogers; Charles F Reynolds; Benoit H Mulsant Journal: Bipolar Disord Date: 2012-03 Impact factor: 6.744
Authors: Roger S McIntyre; Martin Alda; Ross J Baldessarini; Michael Bauer; Michael Berk; Christoph U Correll; Andrea Fagiolini; Kostas Fountoulakis; Mark A Frye; Heinz Grunze; Lars V Kessing; David J Miklowitz; Gordon Parker; Robert M Post; Alan C Swann; Trisha Suppes; Eduard Vieta; Allan Young; Mario Maj Journal: World Psychiatry Date: 2022-10 Impact factor: 79.683
Authors: David Chu; Ariel G Gildengers; Patricia R Houck; Stewart J Anderson; Benoit H Mulsant; Charles F Reynolds; David J Kupfer Journal: Int J Geriatr Psychiatry Date: 2010-12 Impact factor: 3.485
Authors: Ariel G Gildengers; Benoit H Mulsant; Amy Begley; Sati Mazumdar; Adriana V Hyams; Charles F Reynolds Iii; David J Kupfer; Meryl A Butters Journal: Bipolar Disord Date: 2009-08-28 Impact factor: 6.744
Authors: Meredith L Wallace; Burcin Simsek; David J Kupfer; Holly A Swartz; Andrea Fagiolini; Ellen Frank Journal: J Affect Disord Date: 2016-06-07 Impact factor: 4.839
Authors: Margaret O Akinhanmi; Joanna M Biernacka; Stephen M Strakowski; Susan L McElroy; Joyce E Balls Berry; Kathleen R Merikangas; Shervin Assari; Melvin G McInnis; Thomas G Schulze; Marion LeBoyer; Carol Tamminga; Christi Patten; Mark A Frye Journal: Bipolar Disord Date: 2018-03-12 Impact factor: 6.744